Company Overview
- Headquarters
- Montréal CA
- Website
- methylgene.com
- Phone
- (514) 337-****
- Employees
- 57
- Founded in
- 1997
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$10B
Who is MethylGene Inc
MethylGene Inc. is a clinical-stage biopharmaceutical company headquartered in Montréal, Canada. The company currently employs 57 people. MethylGene Inc. is dedicated to the development of novel therapeutics aimed at treating cancer and infectious diseases. MethylGene Inc.’s lead product candidates include MGCD265 and MGCD290. MGCD265 is an oral Met/VEGFR kinase inhibitor currently undergoing Phase 1/2 clinical trials for various types of solid tumors. MGCD290 is a fungal Hos2 inhibitor being investigated for use alongside fluconazole in the treatment of fungal infections. This product candidate has completed Phase 1 clinical studies. The company actively collaborates with leading pharmaceutical companies such as Otsuka Pharmaceutical Co. Ltd., Taiho Pharmaceutical Co. Ltd., and EnVivo Pharmaceuticals, Inc. MGCD265, a novel oral small molecule inhibitor, targets a wide range of receptor tyrosine kinases involved in tumor growth, survival, metastasis, and angiogenesis. For more information about MethylGene Inc. and its therapeutic pipeline, please visit their website at methylgene.com.
MethylGene Inc Industry Tags
Companies Similar to MethylGene Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to MethylGene Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 18 | Arizona City, AZ | 1998 | |
| 10M | 9 | San Diego, CA | ||
| 10M | 6 | Campbell, CA | 2011 | |
| 10M | 2 | Torrington, WY | ||
| 10M | 1 | San Diego, CA | 2016 |